CD274 and non-small cell lung carcinoma: As a major benefit, cell blocks are suitable for immunohistochemical and molecular studies, including the investigation of all common predictive biomarkers for NSCLC therapy (EGFR, KRAS and ALK, ROS1, PD-L1 state).